Get Real Time Here
| Open7.600 | Close7.290 |
| Vol / Avg.1.702M / 1.102M | Mkt Cap428.771M |
| Day Range7.050 - 7.600 | 52 Wk Range5.890 - 29.523 |
Replimune Group Stock (NASDAQ:REPL), Quotes and News Summary
Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
| Open7.600 | Close7.290 |
| Vol / Avg.1.702M / 1.102M | Mkt Cap428.771M |
| Day Range7.050 - 7.600 | 52 Wk Range5.890 - 29.523 |
Earnings
see more| Q3 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.860 | -0.900 | -0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-12-06 | Barclays | Peter Lawson | Maintains | OverweightOverweight | Lowers | 50.00 | 13.00 |
| 2023-11-13 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 50.00 | 48.00 |
| 2023-11-08 | Wedbush | Robert Driscoll | Reiterates | OutperformOutperform | Maintains | - | 52.00 |
| 2023-08-07 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 51.00 | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| REPL | Replimune Group | -4.47% | 428.8M |
| SPRY | ARS Pharmaceuticals | 0.57% | 504M |
| BLUE | bluebird bio | -39.5% | 318.2M |
| CELC | Celcuity | -0.34% | 373M |
| KRRO | Korro Bio | 4.19% | 396.6M |
How do I buy Replimune Group (REPL) stock?
You can purchase shares of Replimune Group (NASDAQ: REPL) through any online brokerage.
Who are Replimune Group's (REPL) competitors?
Other companies in Replimune Group’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), bluebird bio (NASDAQ:BLUE), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO) and LianBio (NASDAQ:LIAN).
What is the target price for Replimune Group (REPL) stock?
The latest price target for Replimune Group (NASDAQ: REPL) was reported by Barclays on Wednesday, December 6, 2023. The analyst firm set a price target for 13.00 expecting REPL to rise to within 12 months (a possible 79.06% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Replimune Group (REPL)?
The stock price for Replimune Group (NASDAQ: REPL) is $7.26 last updated December 8, 2023 at 11:41 PM UTC.
Does Replimune Group (REPL) pay a dividend?
There is no dividend information for Replimune Group.
When is Replimune Group (NASDAQ:REPL) reporting earnings?
Replimune Group’s Q3 earnings are confirmed for Thursday, February 8, 2024.
Is Replimune Group (REPL) going to split?
There is no upcoming split for Replimune Group.
What sector and industry does Replimune Group (REPL) operate in?
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.